Kenya recalls Benylin cough syrup over safety concerns
Health & Science
By
Winfrey Owino
| Apr 11, 2024
The Pharmacy and Poisons Board (PPB) has directed outlets countrywide to stop the distribution of Benylin, a popular brand of children's cough syrup.
Benylin is a product of South African-based pharmaceutical company, Johnson and Johnson.
In a statement by Pharmacy Board, Chief Executive Fred Siyoi said the drug is under scrutiny over its safety and suitability for the Kenyan market.
The board says the decision was reached at after its Nigerian counterpart recalled the drug over safety issues.
READ MORE
Why local BPO sector stands out among its regional peers
IMF boss warns global system not ready for AI cyber threats
State threatens to revoke licenses of 13,000 Saccos over non-compliance
Kenya tightens grip on crypto with Sh500m capital rule
New law aims to protect internal auditors, strengthen public oversight
Ruto launches Sh5.5 billion plan to revamp Voi-Taveta metre gauge railway
Why underwriting is shifting as risk grows more complex
World Bank approves Sh71 billion for Isiolo-Mandera road construction
Banks double lending target to small businesses to hit Sh326b
Contradictions in rural economies 13 years into devolved governance